Adequacy of Parenteral Nutrition in Preterm Infants According to Current Recommendations: A Study in A Spanish Hospital by Sánchez-García, Ana María et al.
International  Journal  of
Environmental Research
and Public Health
Article
Adequacy of Parenteral Nutrition in Preterm Infants
According to Current Recommendations: A Study in
A Spanish Hospital
Ana María Sánchez-García 1, Ana Zaragoza-Martí 2,* , Ana Cristina Murcia-López 1,
Andrés Navarro-Ruiz 1 and Ana Noreña-Peña 2
1 Department of Pharmacy Services, University General Hospital of Elche, 03203 Elche, Spain;
ana25790@gmail.com (A.M.S.G.); murcia_ana@gva.es (A.C.M.L.); navarro_and@gva.es (A.N.R.)
2 Department of Nursing, Faculty of Health Science, University of Alicante, 03690 Alicante, Spain;
ana.norena@ua.es
* Correspondence: ana.zaragoza@ua.es; Tel.: +34-965-903-240
Received: 25 February 2020; Accepted: 21 March 2020; Published: 23 March 2020


Abstract: Background: In preterm infants, it is important to ensure adequate nutritional intake
to accomplish foetal growth requirements. This study evaluated clinical practice regarding the
prescription of parenteral nutrition in preterm infants in the neonatology unit of a tertiary hospital.
Methods: It was a retrospective observational study of a sample of preterm infants (n = 155) born
between January 2015 and December 2017 who were prescribed parenteral nutrition. Compliance with
the hospital’s protocol and with the guidelines of the scientific societies American Society for Parenteral
and Enteral Nutrition (ASPEN), European Society for Clinical Nutrition and Metabolism (ESPEN)
and Spanish Society of Clinical Nutrition and Metabolism (SENPE) was evaluated. The differences
in macronutrient intake and total duration of parenteral nutrition were analysed according to
gestational age and birth weight. Results: The established protocol was followed in a high percentage
(95.5%–100%) except with respect to the initiation of supplying established trace elements (64.9%).
Compliance with the recommendations set forth in the guidelines was between 82.1% and 100%,
with the exception of the initial carbohydrate intake recommended by ASPEN and ESPEN, for which
compliance was 8.3%. Lower gestational age and birth weight were correlated with longer duration
of parenteral nutrition (p < 0.001). Conclusions: A lower gestational age and birth weight are related
to a longer duration of parenteral nutrition. The results of this study demonstrate the importance of
developing and evaluating protocols in clinical practice.
Keywords: preterm newborn; parenteral nutrition; protocols
1. Introduction
Worldwide, prematurity is the leading cause of mortality in children under 5 years of age [1].
It is estimated that 15 million births (11%) occur before 37 weeks of gestation, and the incidence of
preterm births is increasing [2]. In Europe, annual prematurity rates range from 5.2 to 10.4% [3] and are
lower than rates in countries such as the United States (12%) [4]. In Spain, according to the latest data
from the National Institute of Statistics, preterm births account for 6.4% of all births [5]. Although the
incidence of preterm births is increasing, the survival rate of preterm infants, especially in developed
countries, has been increasing in recent years due to advances in medical care, among which is the use
of nutritional support [4].
The preterm population presents a high risk of postnatal malnutrition, and this risk is higher
for infants of low gestational age (GA) because nutritional reserves are lower in younger preterm
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infants [6]. To avoid this risk, nutritional intervention should begin at birth [7]. Initiation of correct
nutrient intake as soon as possible is related to a decrease in postnatal growth restriction; caloric
intake exceeding baseline requirements can improve the growth rate even more, especially in the
most preterm infants, whose nutritional needs are greater [8]. This contributes to preventing the
consequences related to poor growth and to decreasing associated health and social costs, since poor
growth in children is clearly associated with the risk of developing physical or neurological problems
that require greater health and social care, leading to higher costs [9].
To ensure proper nutritional intervention, it is essential that neonatal units develop protocols
based on recommendations that have been validated and agreed upon by scientific societies [10], such
as the guidelines established by American Society for Parenteral and Enteral Nutrition (ASPEN) [11],
European Society for Clinical Nutrition and Metabolism (ESPEN) [12] and Spanish Society of Clinical
Nutrition and Metabolism (SENPE) [13]. These guidelines are important tools that have been validated
by health professionals and that help improve the management of nutritional needs in different
population groups.
The foregoing considerations show that it is important to assess whether the clinical practice
conducted in nutritional interventions in the preterm population is adequate. Currently, published
studies evaluating this clinical topic are scarce, and their results show that care practice differs from the
recommendations established in the guidelines and that in most cases the recommended intake is not
administered; there is also great variability in the prescription of these supplements in different neonatal
care units, and nearly half of such units do not have established protocols [14–18]. Consequently,
studies are needed that centre their objective in evaluating the degree to which hospital services comply
with the established parenteral nutrition (PN) protocols for preterm infants and, in this way, ensure
adequate nutrient intake and achieve proper nutritional monitoring from birth [19].
This study focuses on evaluating whether clinical practice regarding the prescription of PN in
preterm infants in the neonatal unit of a tertiary hospital complies with established protocols and
current published recommendations. In addition, it analyses the differences in macronutrient intake
and total duration of PN as a function of GA and birth weight (BW).
2. Methods
2.1. Design and Study Population
A retrospective observational study was performed in the pharmacy service of a tertiary hospital,
General University Hospital of Elche (Spain), from January 2015 to December 2017. All preterm
infants admitted to the neonatology unit (in which the neonatal intensive care unit is located) that
were prescribed PN (n = 155), excluding those admitted to this unit who initiated PN in other
hospitals, were included in the study. Prematurity was classified according to GA (extremely preterm
if GA < 28 weeks, preterm if GA = 28–34 weeks and late preterm if GA = 34–37 weeks) and according
to BW (≤ 1500 g or >1500 g).
2.1.1. Variables
Among the variables collected were sociodemographic (sex, GA, BW), maternal history (maternal
age, type of pregnancy (multiple or single) and number of pregnancies-abortions-live births (PAL))
and variables related to the medical prescription of PN (initial PN in the first 24 h of life, total days
of PN, initial micronutrient intake on day 1 and maximum intake, prescription on day 1 of vitamins,
zinc and calcium, and prescription on day 4 or 5 of trace elements). The PN variables related to water,
electrolytes (potassium, sodium, chloride and phosphate) and magnesium intake were excluded due to
their clinical variability (dependence on renal function, respiratory and cardiac complications, among
others) and/or variability in analytical data of the newborn.
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2.1.2. Procedure
The data referring to sociodemographic variables and maternal history were collected by a member
of the research team through the hospital management software Mizar®. This is electronic programme
used and developed in Valencian Community. For data related to prescribed PN intake, the manual
prescriptions made by the paediatrician and sent to the pharmacy service and the information in
the HospiWin®2000 v8 programme used for formulation of PN by the responsible pharmacist were
reviewed. The pharmacist enters the nutritional intakes prescribed by the doctor and the data of the
newborn as the weight in the Hospiwin program. This program calculates the total nutrient intake
that must be prepared to administer to the newborn.
2.1.3. Ethical Considerations
The present study was conducted according to the ethical standards of biomedical research and
data protection set forth in the Declaration of Helsinki. This study was evaluated and approved by the
Research Ethics Committee of the General University Hospital of Elche in May 2018 (code PI 17/2018).
To ensure data confidentiality, patient identification was coded.
2.1.4. Statistical Analysis
The statistical package IBM SPSS Statistics v.23.0 (IBM Company, Spain) for Windows was used
to perform the statistical analysis. The categorical variables were analysed using frequencies; the
quantitative variables are expressed as the mean (± SD) when the values follow a normal distribution
and as the median (± IQR) when the values not follow a normal distribution. The X2 test was used to
compare categorical data, and the Kruskal–Wallis and Mann–Whitney U tests were used to compare
quantitative data, assigning a significance level of 0.05. Spearman’s rho coefficient was used to
determine the association between total days of PN and GA and BW.
3. Results
Table 1 shows the distribution of sociodemographic and maternal history variables. A total of
52.8% of the preterm infants were male, and there were no statistically significant differences with
respect to the types of preterm birth. The mean GA was 30.0 (± 3.0) weeks, and the median BW was
1200 (±558) grams. Single-foetus pregnancies accounted for 67.7% of the cases, with no differences
between groups. Regarding maternal history, the median maternal age was 33.0 (± 9.0) years, with no
statistically significant differences between groups. A total of 66.2% of the mothers had been pregnant
before and the 47.7% had had abortions, and 60.3% had more than one lived child; none of these
parameters differed significantly among the groups, although a higher percentage of abortions was
observed in the extremely preterm group (61.8%).
The general distribution of prescribed nutritional doses of nutrients can be seen in Table 2. In 84%
of preterm infants who received PN, PN was prescribed during the first day of life; the median intake
of protein, lipids and carbohydrates was 2.0 (±0.5), 1.0 (±0.5) and 7.0 (±0.5) g/kg/day, respectively.
The median maximum macronutrient intake was 3.0 (±0.2) g/kg/day in the case of proteins, 3.0 (±0.5)
g/kg/day in the case of lipids and 11.0 (±2.5) g/kg/day in the case of carbohydrates. In only one case
(0.6%) was the initiation of calcium and zinc not prescribed on the first day; 97.4% of the infants were
prescribed vitamins on the first day. On the other hand, 35.1% did not receive trace elements on days 4
or 5, although of these, 86.7% initiated trace element intake on day 6.
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Table 1. Sociodemographic variables and maternal history.
Extremely Preterm Preterm Late Preterm
p-Value(<28 Weeks) (28–34 Weeks) (34–37 Weeks)
(n = 37) (n = 98) (n = 20)
Sex
p = 0.550 *Male 45.9 (17)) 56.1 (55) 50.0 (10)
Female 54.1 (20) 43.9 (43) 50.0 (10)
(%(n))
GA (weeks) 26.3 (±1.3) 30.6 (±1.7) 34.7 (±0.7)
mean(±SD)
Birth weight (grams) 905.0 (±351.0) 1300.0 (±423.0) 1930.0 (±1000.0)
median(±IQR)
Maternal age (years) 31.0 (±11.0) 31.5 (±8.0) 34.0 (±7.0) p = 0.137 **
median(±IR)
Pregnancy 81.1 (30)
p = 0.110 *Simple 18.9 (7) 62.2 (61) 70.0 (14)
Multiple 37.8 (37) 30.0 (6)
(%(n))
Gestation
p = 0.351 *1 gestation 23.5 (8) 37.1 (36) 35.0 (7)
>1 gestation 76.5 (26) 62.9 (61) 65.0 (13)
(%(n))
Previous abortions
p = 0.173 *Yes
No 61.8 (21) 43.3 (42) 45.0 (9)
(%(n)) 38.2 (13) 56.7 (55) 55.0 (11)
Live children
p = 0.829 *1 Live 44.1 (15) 38.1 (37) 40.0 (8)
>1 Live 55.9 (19) 61.9 (60) 60.0 (12)
(%(n))
Data are expressed as % (n) or means (±SD) or medians (± IQR), as appropriate. No differences between groups
according to the different variables. * X2 Test ** Kruskal–Wallis Test GA: gestacional age.
Table 2. Distribution of prescribed intakes.
Initiation PN Postnatal day 1
(% (n))
84 (130) Yes
16 (25) No
Initiation proteins (g/kg/day)
(median ± IQR) 2.0 (±0.5)
Maximum proteins (g/kg/day)
(median ± IQR) 3.0 (±0.2)
Initiation lipids (g/kg/day)
(median ± IQR) 1.0 (±0.5)
Maximum lipids (g/kg/day)
(median ± IQR) 3.0 (±0.5)
Initiation CHO (g/kg/day)
(median ± IQR) 7.0 (±0.5)
Maximum CHO (g/kg/day)
(median ± IQR) 11.0 (±2.5)
Initiation calcium first day
(% (n))
99.4 (154) Yes
0.6 (1) No
Initiation zinc first day
(% (n))
99.4 (154) Yes
0.6 (1) No
Initiation trace elements 4th-5th day
(% (n))
64.9 (85) Yes
35.1 (46) No
Initiation vitamins first day
(% (n))
97.4 (151) Yes
2.6 (4) No
Data are expressed as % (n) or medians (±IQR), as appropriate PN: parenteral nutrition; CHO: carbohydrates.
A comparison of the PN prescriptions with the recommendations of scientific societies (SENPE,
ESPEN and ASPEN) and with the recommendations established in the hospital protocol is shown in
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Table 3. The results show that the macronutrient intakes were adjusted to the established hospital
protocol (compliance was 95.5% to 100%), as was the initiation of calcium (99.4%), zinc (99.4%) and
vitamins (97.4%) However, as indicated, in preterm infants who continued with PN for more than 4 days,
the initiation of trace elements on days 4 or 5 was not frequently prescribed (35.1%), with compliance
in this case of 64.9%.
Table 3. Compliance with the guidelines published by SENPE, ESPEN and ASPEN and with the
established hospital protocol.
SENPE
2017
Compliance
(%(n))
ESPEN
2005
Compliance
(%(n))
ASPEN
2002
Compliance
(%(n))
Hospital
Protocol
Compliance
(%(n))
Initiation PN
Postnatal
day 1
84 (130) Yes Postnatal
day 1
84 (130) Yes Postnatal
day 1
84 (130) Yes Postnatal
day 1
84 (130) Yes
16 (25) No 16 (25) No 16 (25) No 16 (25) No
Initiation
minimum CHO
8.6
8.3 (13) Yes
5.8
99.4 (154) Yes
8.6
8.3 (13) Yes
6
98.7 (153) Yes
(g/kg/day) 91.7 (142) No 0.6 (1) No 91.7 (142) No 1.3 (2) No
Maximum CHO
17.3
99.4 (154) Yes
12
82.1 (127) Yes
18.7
100 (155) Yes
18
100 (155) Yes
(g/kg/day) 0.6 (1) No 17.9 (28) No 0 (0) No 0 (0) No
Initiation
minimum lipids
0.5
98.1 (152) Yes
0.25
98.1 (152) Yes
0.5
98.1 (152) Yes
0.5
98.1 (152) Yes
(g/kg/day) 1.9 (3) No 1.9 (3) No 1.9 (3) No 1.9 (3) No
Maximum lipids
4
100 (155) Yes
4
100 (155) Yes
3
98.1 (152) Yes
3
98.1 (152) Yes
(g/kg/day) 0 (0) No 0 (0) No 1.9 (3) No 1.9 (3) No
Initiation
minimum
proteins 1.5
95.5 (148) Yes
1.5
95.5 (148) Yes
1
100 (155) Yes
1.5
95.5 (148) Yes
(g/kg/day) 4.5 (7) No 4.5 (7) No 0 (0) No 4.5 (7) No
Maximum
proteins 4
100 (155) Yes
4
100 (155) Yes
3.85
100 (155) Yes
4
100 (155) Yes
(g/kg/day) 0 (0) No 0 (0) No 0 (0) No 0 (0) No
Initiation day
calcium
- - - Postnatal
day 1
99.4 (154) Yes
0.6 (1) No
Initiation day
zinc
- - - Postnatal
day 1
99.4 (154) Yes
0.6 (1) No
Initiation day
trace elements
- - - Postnatal
day 4–5
64.9 (85) Yes
35.1 (46) No
Initiation day
vitamins
- Postnatal
day 1
97.4 (151) Yes - Postnatal
day 4–5
97.4 (151) Yes
2.6 (4) No 2.6 (4) No
The compliance is shown %(n) for each data, yes (there is compliance), no (there is not compliance) PN: parenteral
nutrition; CHO: carbohydrates.
Concerning compliance with the guidelines, there were differences in the recommendations
regarding macronutrients. The initial carbohydrate intake recommended in the SENPE 2017 and
ASPEN 2002 guidelines is higher than that recommended in the ESPEN 2005 and hospital protocol,
so that our prescriptions adjusted by 8.3%. Compliance with the remaining recommendations for
macronutrients was between 82.1% and 100%, with no significant differences among them. In this case,
the compliance with recommended levels of the studied micronutrients could not be evaluated because
these guidelines do not specify when micronutrient supplementation should be initiated. The only
specification is for initiation of vitamins on the first day of life, and this is found only in the ESPEN
guidelines. In this study, compliance with this recommendation was 97.4%.
The analysis of macronutrient intake and total days of PN as a function of the type of prematurity
according to GA is detailed in Table 4. The results show that there were statistically significant differences
within groups in the prescription of maximum lipid intake and the initiation of carbohydrates; these
were lower and higher, respectively, in the case of late preterm infants. With respect to the other
supplements, there were no differences among the groups. On the other hand, there were significant
differences in the total days of PN; this was higher in the extremely preterm group.
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Table 4. Distribution of prescribed macronutrient intake according to gestational age.
Macronutrient
Intake and Total
Days PN
Extremely Preterm
(<28 Weeks)
(n = 37)
(Median ± IQR)
Preterm
(28–34 Weeks)
(n = 98)
(Median ± IQR)
Late Preterm
(34–37 Weeks)
(n = 20)
(Median ± IQR)
p-Value
Initiation proteins 2.0 (±0.5) 2.0 (±0.5) 2.0 (±1.0) p = 0.159 *
(g/kg/day)
Maximum proteins 3.0 (±0.25) 3.0 (±0.2) 2.9 (±0.5) p = 0.086 *
(g/kg/day)
Initiation lipids 1.0 (±0.5) 1.0 (±0.5) 1.25 (±0.95) p = 0.141 *
(g/kg/day)
Maximum lipids 3.0 (±0.5) 3.0 (±0.5) 2.5 (±1.0) p = 0.003 *
(g/kg/day)
Initiation CHO 6.5 (±0.75) 7.0 (±0.5) 8.0 (±2.38) p < 0.001 *
(g/kg/day)
Maximum CHO 11.0 (±3.0) 11.0 (±2.0) 10.75 (±2.63) p = 0.823 *
(g/kg/day)
Total days PN 14.0 (±10.0) 8.0 (±6.0) 5.0 (±3.0) p < 0.001 *
(days)
* Kruskal–Wallis test, CHO: carbohydrates; PN: parenteral nutrition.
A comparison of very low birth weight preterm infants (≤1500 g) with infants heavier than
1500g detailed in Table 5 shows that there were significant differences in the maximum protein and
lipid intake; the intakes were higher in the group of preterm infants with BW≤1500 g in both cases.
There were also significant differences in the initial carbohydrate intake, which was higher in the case
of preterm infants with BW >1500 g. On the other hand, no significant differences in the initial intake
of proteins and lipids were found. The total duration in days of PN was higher in the group of preterm
infants with BW ≤ 1500 g.
Table 5. Distribution of prescribed macronutrient intake according to birth weight.
Macronutrient Intake
and Total Days PN
BW ≤ 1500g
(n = 117)
(Median ± IQR)
BW >1500 g
(n = 38)
(Median ± IQR)
p-Value
Initiation proteins 2.0 (±0.5) 2.0 (±0.5) p = 0.068 *
(g/kg/day)
Maximum proteins 3.0 (±0.2) 3.0 (±0.5) p = 0.002 *
(g/kg/day)
Initiation lipids 1.0 (±0.5) 1.0 (±0.5) p = 0.838 *
(g/kg/day)
Maximum lipids 3.0 (±0.5) 2.5 (±1.0) p < 0.001 *
(g/kg/day)
Initiation CHO 7.0 (±0.5) 7.0 (±1.38) p = 0.003 *
(g/kg/day)
Maximum CHO 11.0 (±2.13) 10.25 (±2.13) p = 0.130 *
(g/kg/day)
Total days PN 10.0 (±9.0) 5.0 (±2.0) p < 0.001*
(days)
* Mann–Whitney U tests, BW: birth weight; CHO: carbohydrates; PN: parenteral nutrition.
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There were statistical and negative correlations between number of day with PN and GA
(rs = −0.513) and BW (rs = −0.514) There was a moderate relationship, with the total number of days of
PN being greater for lower GA and lower BW.
4. Discussion
This study aimed to evaluate clinical practice in the neonatal unit of a tertiary hospital regarding
the prescription of PN in preterm infants. The findings show that medical prescriptions conform
to the protocol established in that hospital. In general, they also conform to the recommendations
set forth in the guidelines of scientific societies (ASPEN, ESPEN and SENPE), although there are
small differences in the guidelines for recommended macronutrient intake; for example, in the ESPEN
guidelines, the recommended initiation of carbohydrates differs from that established in the ASPEN
and SENPE guidelines.
Prematurity is associated with growth delay, especially with delays in neurocognitive
development [20,21], as well as with other possible related consequence [22]. Many cases present
restriction of postnatal growth below the 10th percentile [23], and this restriction is inversely
proportional to gestational age [6]. This is due, in large part, to the nutritional deficit that develops from
insufficient administration of nutrient [24]. In addition, the limited reserves of nutrients possessed
by these infants cause a compromised nutritional status, making the use of PN [25] fundamental
in preventing the catabolism that would otherwise occur when the continuous supply of placental
nutrients ceases [26]. Therefore, from birth, adequate nutritional intake must be provided to preterm
infants to meet foetal growth requirements [27,28].
Currently, in contrast to the classic administration of glucose during the first days of life, the concept
of “aggressive nutrition”, which involves the early administration of lipids and a significant supply
of protein along with high glucose from the first hours of life, has emerged [29]. In the case of
newborns with BW<1500 g, the most recent studies show that greater protein and lipid intake (2.4 and
2g/kg/day, respectively) from the first day is safe and that it improves the infants’ nitrogen balance
provided that the appropriate ratio of 25–40kcal non-protein/g protein is used [30]. Higher protein
intake (3–4g/kg/day together with lipids) has not been shown to improve nitrogen balance and is also
associated with increased plasma urea [30,31] and not associated with improvement in growth or
neurological development [32]. Our data show that there are no differences in the initial protein and
lipid intake according to GA and BW; therefore, it would be advisable to evaluate whether the use of
higher intake levels in the most preterm infants should be recommended.
Regarding the intake of the micronutrients studied, our results also conform to the
recommendations established in the hospital protocol; it is noteworthy that the initiation of trace
elements on day 4 or 5 shows a compliance of 64.9%. This may be due to an inaccurate control of
days of PN, because 86.7% of preterm infants for whom trace elements were not initiated on the
established days began receiving trace elements on day 6. It should be noted that the published
guidelines of the ASPEN, SENPE and ESPEN scientific societies do not specify when administration of
these micronutrients should begin; this should be reviewed, because a consensus that specifies how
these micronutrients should be supplied is needed [33].
In a general sense, there are studies that reflect the importance of adequate micronutrient intake
in preterm infants and show that it is important to ensure their administration because some problems
in growth have been related to an insufficient supply of these nutrients [34]. The administration of
calcium from the first day of life is advised and is necessary to avoid the characteristic hypocalcaemia
that often develops in preterm infants [35]. The trace elements, in particular zinc, which is a necessary
cofactor for numerous important enzymes, must be supplemented in PN from birth [36–38]. In addition,
insufficient vitamin intake should be avoided because it may also be involved in the development
of disorders such as bronchopulmonary dysplasia, osteopaenia and intraventricular haemorrhage,
among others [36].
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On the other hand, the administration of PN should be accompanied whenever possible by the
concomitant use of the enteral route, even if it is trophic. Maintenance of trophism improves intestinal
maturation and provides other benefits such as improving postnatal growth, cardiac and respiratory
diseases and reducing the risk of infections [39]. It must be taken into account that a long duration of
PN can lead to complications, mainly infections [40] or metabolic complications (hyperlipidaemias,
hyperbilirubinaemia, cholestasis) [41]. Therefore, PN should be terminated when it is possible to
orally administer a sufficient amount of enteral nutrition (EN) to satisfy the minimum nutritional
requirements equivalent to those achieved during foetal development [42]. In this study, data on EN
prescriptions could not be collected; however, as expected, longer duration of PN was associated with
lower GA and lower BW. This corroborates the finding that enteral tolerance in the most preterm births
is achieved with great difficulty due to the infants’ gastrointestinal immaturity [24].
As for the assessment of how nutritional practice is currently being conducted in neonatal intensive
care units, studies are scarce. For the most part, such studies gather information through questionnaires
that are sent to specialists in neonatal intensive care, such as neonatologists, nurses and neonatal
dietitians [14,17,18]. There is a risk that the data obtained in this way do not reflect the actual practice
but are instead based on what would be done in theory.
Some studies have analysed real data on the prescription of supplements in preterm infants in
clinical practice [15–17]. In this line, one study evaluated energy and macronutrient intake by the
parenteral route and/or from enriched breast milk during the first postnatal week, with data collection
until day 8 (DoMINO clinical trial) [15]. The authors emphasized the importance of adequate intake
not only during the first days of life but beyond; they observed that although the recommended
values were reached on days 6 and 7.34% and 71% of very low birth weight preterm infants did
not meet the established protein and energy requirements, respectively, on day 8 [15]. According to
another study conducted in the United Kingdom in which 264 cases of neonatal PN were reviewed,
there was recognition of the importance of deficiency of the correct administration of PN at the care
level; in 37% of the cases, the initial prescription of PN was inadequate, and in 19%, follow-up was
inappropriate [16].
In another worldwide study in which 52 countries participated, a questionnaire on the nutritional
strategies developed in each paediatric intensive care unit (PICU) was distributed, and the results were
compared with real data from clinical practice. Differences were found that reflected an overestimation
of the ability to adequately feed neonates. The results indicated that only 55% of PICUs initiated PN
within 48 h of birth in patients with intolerance to EN. In general, this would be used in 72% of PICUs if
EN intake did not comply with at least 50% of the caloric targets. It is important to emphasize that only
52% of these centres had an established nutritional management protocol [17]. In our study, the high
compliance with the protocol by the medical staff shows that the development of nutritional protocols
in PICUs is a good tool that helps ensure proper nutritional monitoring of preterm newborns [43].
Regarding the limitations of this study, it is noteworthy that only PN data were collected and
that the supply of EN/breastmilk that patients received is unknown, although the enteral supply of
nutrients does not contribute to the analysed data, in this study total caloric intake is not analysed,
the macronutrient intake analysed refers to the minimum initial and maximum intake reached, so
the supply of EN/breast milk does not influence. In addition, pathologies and/or complications that
may have developed in preterm infants were not identified because the hospital protocol did not
establish intake based on them, and these data were not documented in the programmes used. Finally,
it must be taken into account that due to the low prevalence of preterm infants who also require PN,
a total number of 155 preterm infants (over a period of 3 years) was obtained; when these infants are
divided into groups, the sample number is reduced significantly in some cases, making it impossible
to extrapolate the data. This limitation also makes it impossible to analyse other health outcomes such
as survival rates compared compliance with the hospital protocol. This demonstrates the need for
larger and multicentre studies that can produce results with greater statistical power.
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This study concludes that there is a high percentage of compliance with both the nutritional
protocol established in the neonatal care unit of a tertiary hospital and its suitability as judged by
comparison with the recommendations of the scientific societies ASPEN, ESPEN and SENPE. On the
other hand, our findings show that lower GA and BW are related to longer duration of PN and that
the initial protein and lipid intake prescribed do not differ in a way that is related to these variables.
In addition, the results of this study demonstrate the importance of preparing and evaluating protocols
in clinical practice and the need to adapt the PN of preterm neonates to clinical protocols. For this
reason, more studies analysing the management of PN in the preterm population are needed, given
the scarce current evidence supplied in national and international studies. Future research should
focus on establishing a consensus regarding the intake requirements in this population group. This
would also make it possible to obtain more comprehensive and detailed information on the specific
intake of micronutrients and trace elements.
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